{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:39:13Z","timestamp":1791722353652,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11010-018-3288-x","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T23:40:23Z","timestamp":1516837223000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The toxic nature of murine amylin and the immune responsivity of pancreatic islet to conformational antibody in mice"],"prefix":"10.1007","volume":"447","author":[{"given":"Luiza C. S.","family":"Erthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Jotha-Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Alves","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Alves","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo Miguel","family":"de Oliveira Pascarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthia Melo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleber L. A.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6020-0504","authenticated-orcid":false,"given":"Lu\u00eds Maur\u00edcio T. R.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"3288_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1084\/jem.5.5.527","volume":"5","author":"EL Opie","year":"1901","unstructured":"Opie EL (1901) The relation Oe diabetes mellitus to lesions of the pancreas. hyaline degeneration of the islands Oe Langerhans. J Exp Med 5:527\u2013540","journal-title":"J Exp Med"},{"key":"3288_CR2","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper GJ, Willis AC, Clark A et al (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628\u20138632","journal-title":"Proc Natl Acad Sci USA"},{"key":"3288_CR3","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E et al (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84:3881\u20133885","journal-title":"Proc Natl Acad Sci USA"},{"key":"3288_CR4","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Engstr\u00f6m U, Johnson KH et al (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87:5036\u20135040","journal-title":"Proc Natl Acad Sci USA"},{"key":"3288_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nsb0502-318","volume":"9","author":"CM Deber","year":"2002","unstructured":"Deber CM, Therien AG (2002) Putting the \u03b2-breaks on membrane protein misfolding. Nat Struct Mol Biol 9:318\u2013319. \n                    https:\/\/doi.org\/10.1038\/nsb0502-318","journal-title":"Nat Struct Mol Biol"},{"key":"3288_CR6","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2146\/ajhp050341","volume":"62","author":"J McQueen","year":"2005","unstructured":"McQueen J (2005) Pramlintide acetate. Am J Health Syst Pharm 62:2363\u20132372. \n                    https:\/\/doi.org\/10.2146\/ajhp050341","journal-title":"Am J Health Syst Pharm"},{"key":"3288_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpc.2016.09.007","volume":"219","author":"DC Silva da","year":"2016","unstructured":"da Silva DC, Fontes GN, Erthal LCS, Lima LMTR. (2016) Amyloidogenesis of the amylin analogue pramlintide. Biophys Chem 219:1\u20138. \n                    https:\/\/doi.org\/10.1016\/j.bpc.2016.09.007","journal-title":"Biophys Chem"},{"key":"3288_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bpc.2013.07.013","volume":"180\u2013181","author":"LC Palmieri","year":"2013","unstructured":"Palmieri LC, Melo-Ferreira B, Braga CA et al (2013) Stepwise oligomerization of murine amylin and assembly of amyloid fibrils. Biophys Chem 180\u2013181:135\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.bpc.2013.07.013","journal-title":"Biophys Chem"},{"key":"3288_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bpc.2016.09.008","volume":"218","author":"LCS Erthal","year":"2016","unstructured":"Erthal LCS, Marques AF, Almeida FCL et al (2016) Regulation of the assembly and amyloid aggregation of murine amylin by zinc. Biophys Chem 218:58\u201370. \n                    https:\/\/doi.org\/10.1016\/j.bpc.2016.09.008","journal-title":"Biophys Chem"},{"key":"3288_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/acs.biochem.5b01107","volume":"55","author":"AG Wong","year":"2016","unstructured":"Wong AG, Wu C, Hannaberry E et al (2016) Analysis of the amyloidogenic potential of pufferfish (Takifugu rubripes) islet amyloid polypeptide highlights the limitations of thioflavin-T assays and the difficulties in defining amyloidogenicity. Biochemistry 55:510\u2013518. \n                    https:\/\/doi.org\/10.1021\/acs.biochem.5b01107","journal-title":"Biochemistry"},{"key":"3288_CR11","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0022-2836(02)01377-3","volume":"326","author":"J Green","year":"2003","unstructured":"Green J, Goldsbury C, Mini T et al (2003) Full-length rat amylin forms fibrils following substitution of single residues from human amylin. J Mol Biol 326:1147\u20131156","journal-title":"J Mol Biol"},{"key":"3288_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.micron.2012.07.001","volume":"44","author":"NGN Milton","year":"2013","unstructured":"Milton NGN, Harris JR (2013) Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide. Micron 44:246\u2013253. \n                    https:\/\/doi.org\/10.1016\/j.micron.2012.07.001","journal-title":"Micron"},{"key":"3288_CR13","doi-asserted-by":"publisher","first-page":"42803","DOI":"10.1074\/jbc.M406108200","volume":"279","author":"DHJ Lopes","year":"2004","unstructured":"Lopes DHJ, Colin C, Degaki TL et al (2004) Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP). J Biol Chem 279:42803\u201342810. \n                    https:\/\/doi.org\/10.1074\/jbc.M406108200","journal-title":"J Biol Chem"},{"key":"3288_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","volume":"176","author":"T Gurlo","year":"2010","unstructured":"Gurlo T, Ryazantsev S, Huang C et al (2010) Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol 176:861\u2013869. \n                    https:\/\/doi.org\/10.2353\/ajpath.2010.090532","journal-title":"Am J Pathol"},{"key":"3288_CR15","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.2337\/db06-1755","volume":"57","author":"WPS Wong","year":"2008","unstructured":"Wong WPS, Scott DW, Chuang C-L et al (2008) Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance. Diabetes 57:2737\u20132744. \n                    https:\/\/doi.org\/10.2337\/db06-1755","journal-title":"Diabetes"},{"key":"3288_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"3288_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","volume":"309","author":"H LeVine","year":"1999","unstructured":"LeVine H (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309:274\u2013284","journal-title":"Methods Enzymol"},{"key":"3288_CR18","doi-asserted-by":"publisher","first-page":"36086","DOI":"10.1074\/jbc.M111.240762","volume":"286","author":"S Trikha","year":"2011","unstructured":"Trikha S, Jeremic AM (2011) Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol. J Biol Chem 286:36086\u201336097. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.240762","journal-title":"J Biol Chem"},{"key":"3288_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2337\/db12-1326","volume":"62","author":"S Costes","year":"2013","unstructured":"Costes S, Langen R, Gurlo T et al (2013) \u03b2-Cell failure in type 2 diabetes: a case of asking too much of too few? Diabetes 62:327\u2013335. \n                    https:\/\/doi.org\/10.2337\/db12-1326","journal-title":"Diabetes"},{"key":"3288_CR20","doi-asserted-by":"publisher","first-page":"29639","DOI":"10.1074\/jbc.R800016200","volume":"283","author":"CG Glabe","year":"2008","unstructured":"Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283:29639\u201329643. \n                    https:\/\/doi.org\/10.1074\/jbc.R800016200","journal-title":"J Biol Chem"},{"key":"3288_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/joim.12500","volume":"280","author":"M Landreh","year":"2016","unstructured":"Landreh M, Sawaya MR, Hipp MS et al (2016) The formation, function and regulation of amyloids: insights from structural biology. J Intern Med 280:164\u2013176. \n                    https:\/\/doi.org\/10.1111\/joim.12500","journal-title":"J Intern Med"},{"key":"3288_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2008.10.009","volume":"153","author":"H-L Zhao","year":"2009","unstructured":"Zhao H-L, Sui Y, Guan J et al (2009) Amyloid oligomers in diabetic and nondiabetic human pancreas. Transl Res J Lab Clin Med 153:24\u201332. \n                    https:\/\/doi.org\/10.1016\/j.trsl.2008.10.009","journal-title":"Transl Res J Lab Clin Med"},{"key":"3288_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S2213-8587(17)30011-6","volume":"5","author":"LMTR Lima","year":"2017","unstructured":"Lima LMTR. (2017) Prediabetes definitions and clinical outcomes. Lancet Diabetes Endocrinol 5:92\u201393. \n                    https:\/\/doi.org\/10.1016\/S2213-8587(17)30011-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3288_CR24","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765201720160394","author":"LMTR Lima","year":"2017","unstructured":"Lima LMTR (2017) Subclinical diabetes. An Acad Bras Ci\u00eanc. \n                    https:\/\/doi.org\/10.1590\/0001-3765201720160394","journal-title":"An Acad Bras Ci\u00eanc"},{"key":"3288_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2337\/db06-1579","volume":"56","author":"C-Y Lin","year":"2007","unstructured":"Lin C-Y, Gurlo T, Kayed R et al (2007) Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice. Diabetes 56:1324\u20131332. \n                    https:\/\/doi.org\/10.2337\/db06-1579","journal-title":"Diabetes"},{"key":"3288_CR26","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1096\/fj.14-251744","volume":"28","author":"S Zhang","year":"2014","unstructured":"Zhang S, Liu H, Chuang CL et al (2014) The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet \u03b2 cells. FASEB J 28:5083\u20135096. \n                    https:\/\/doi.org\/10.1096\/fj.14-251744","journal-title":"FASEB J"},{"key":"3288_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1074-5521(96)90118-0","volume":"3","author":"TT Ashburn","year":"1996","unstructured":"Ashburn TT, Han H, McGuinness BF, Lansbury PT (1996) Amyloid probes based on congo red distinguish between fibrils comprising different peptides. Chem Biol 3:351\u2013358","journal-title":"Chem Biol"},{"key":"3288_CR28","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1021\/acs.biochem.5b00309","volume":"54","author":"ND Younan","year":"2015","unstructured":"Younan ND, Viles JH (2015) A comparison of three fluorophores for the detection of amyloid fibers and prefibrillar oligomeric assemblies. ThT (Thioflavin T); ANS (1-anilinonaphthalene-8-sulfonic acid); and bisANS (4,4\u2032-dianilino-1,1\u2032-binaphthyl-5,5\u2032-disulfonic acid). Biochemistry 54:4297\u20134306. \n                    https:\/\/doi.org\/10.1021\/acs.biochem.5b00309","journal-title":"Biochemistry"},{"key":"3288_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL et al (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489. \n                    https:\/\/doi.org\/10.1126\/science.1079469","journal-title":"Science"},{"key":"3288_CR30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","volume":"53","author":"S Zraika","year":"2010","unstructured":"Zraika S, Hull RL, Verchere CB et al (2010) Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia 53:1046\u20131056. \n                    https:\/\/doi.org\/10.1007\/s00125-010-1671-6","journal-title":"Diabetologia"},{"key":"3288_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4161\/isl.1.2.9480","volume":"1","author":"A Kim","year":"2009","unstructured":"Kim A, Miller K, Jo J et al (2009) Islet architecture: a comparative study. Islets 1:129\u2013136. \n                    https:\/\/doi.org\/10.4161\/isl.1.2.9480","journal-title":"Islets"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-018-3288-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T02:39:28Z","timestamp":1548383968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-018-3288-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3288"],"URL":"https:\/\/doi.org\/10.1007\/s11010-018-3288-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/175539","asserted-by":"object"}]},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"11 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no financial conflicts of interest with the contents of this article. LMTRL is a participant in patent applications by the UFRJ on controlled release of peptides.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}